首页> 美国卫生研究院文献>Journal of Young Pharmacists : JYP >Formulation and Evaluation of Cephalexin Extended Release Matrix Tablets Using 32 Factorial Design
【2h】

Formulation and Evaluation of Cephalexin Extended Release Matrix Tablets Using 32 Factorial Design

机译:使用32因子设计的头孢氨苄缓释基质片剂的制备和评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the present investigation was to prepare extended release film coated matrix tablets of cephalexin using binary mixture of two grades of hydrophilic polymer, hydroxypropyl methyl cellulose (HPMC), by direct compression method. Results of the preliminary trials indicated that the polymers used have significant release retarding effect on the formulation. To study the effect of concentration of polymers on drug release from matrix tablets, 32 full factorial design was applied. The concentration of HPMC K15M and HPMC 15cps were used as independent variables, while percentage drug release was selected as dependent variable. The dissolution data were fitted into zero-order, first-order, Higuchi and Korsemeyer–Peppas models to identify the pharmacokinetics and mechanism of drug release. Comparative study of dissolution profile of final batch F3 with market preparation (Sporidex AF 375) was done by similarity factor (f2) determination and it was concluded that final formulation F3 (10% HPMC K15M, 17.5% HPMC 15cps) shows good similarity with the market product. The results of the accelerated stability study of final formulation F3 for 1 month revealed that storage conditions were not found to have made any significant changes in final formulation F3. The release of cephalexin was prolonged for 6 h by using polymer combinations of HPMC and a twice daily matrix tablet was formulated.
机译:本研究的目的是使用两种等级的亲水性聚合物羟丙基甲基纤维素(HPMC)的二元混合物通过直接压制法制备头孢氨苄的缓释膜包衣基质片剂。初步试验结果表明,所用聚合物对制剂具有显着的缓释作用。为了研究聚合物浓度对基质片剂中药物释放的影响,采用3 2 全因子设计。 HPMC K15M和HPMC 15cps的浓度用作自变量,而选择药物释放百分比作为因变量。将溶出度数据拟合为零阶,一阶,Higuchi和Korsemeyer-Peppas模型,以确定药物动力学和药物释放机理。通过相似系数(f2)的测定完成了最终批次F3与市场准备品(Sporidex AF 375)的溶出度曲线的比较研究,并得出结论,最终配方F3(10%HPMC K15M,17.5%HPMC 15cps)与样品F3的相似性很好。市场产品。最终制剂F3的1个月加速稳定性研究的结果表明,未发现储存条件对最终制剂F3进行了任何重大更改。通过使用HPMC的聚合物组合,头孢氨苄的释放延长了6小时,并配制了每日两次的基质片剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号